FDA Pregnancy
Registry Brochure

Roberts SS, Miller, RK, Jones, JK, Lindsay KL, Greene MF, Maddrey WC, Williams IT, Liu J, Spiegel RJ. (2010) The Ribavirin Pregnancy Registry: Findings after 5 Years of Enrollment, 2003-2009. Birth Defects Res A Clin Mol Teratol, 88:551-559 (2010).

Roberts SS. Assessing Ribavirin Exposure During Pregnancy: The Ribavirin Pregnancy Registry. Gastroenterology Nursing. 2008 November/December 31 (6); 413-417

Miller RK. Roberts S, Chambers C, Greene MF. Peri-FACTS® Case #942: Safety of medications during pregnancy: the importance of prospective studies, pregnancy registries, and healthcare provider collaboration. Peri-FACTS. An e-journal for Lifelong Learning in Obstetrics, From the University of Rochester's, Department of Obstetrics and Gynecology, May 2011

::: Click Here To View the PeriFacts article :::
Case Example 27: Using Proactive Awareness Activities To Recruit Patients for a Pregnancy Exposure Registry. In: Gliklich RE, Dreyer NA, eds. Registries for Evaluating Patient Outcomes: A Users Guide. 2nd ed. (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. d/b/a Outcome] under Contract No. HHSA29020050035I TO3.) AHRQ Publication No.10-EHC049. Rockville, MD: Agency for Healthcare Research and Quality. September 2010

Sinclair SM, Miller RK, Chambers C, Cooper EM. Medication Safety During Pregnancy: Improving Evidence-Based Practice. Journal of Midwifery & Women's Health. January/February 2016 issue.

Sinclair SM, Jones JK, Miller RK, Kwo PY, Greene MF, Thorpe PG, Maddrey WC. The Ribavirin Pregnancy Registry: An Interim Analysis At The Mid-Point Of Enrollment. Volume: 38 Issue: 10 Pages: 1027-1027 Meeting Abstract: P 149, OCT 2015. Poster presentation at the 15th Annual Meeting of the International-Society-of-Pharmacovigilance (ISoP), Prague, Czech Republic, October 27-30, 2015

Copyright © 2005
All rights reserved
INC Research